Clinical Trials Directory

Trials / Completed

CompletedNCT01618864

Safety and Efficacy of the Luxe Device to Treat Facial Wrinkles and Rosacea

Safety and Efficacy Evaluation of the Luxe™ Device for the Treatment of Facial Wrinkles and Rosacea

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
23 (actual)
Sponsor
Syneron Medical · Industry
Sex
All
Age
21 Years – 60 Years
Healthy volunteers
Accepted

Summary

This study is designed to evaluate the efficacy and safety of the Luxe™ device for use in wrinkle and rosacea treatment. Up to 60 subjects will treat their periorbital and cheek areas daily for 4 weeks and then twice a week for an additional 4 weeks. Evaluations of improvement will be conducted at the clinic after enrollment and during the treatment at 1, 2, 4, and 8 weeks after initiation.

Conditions

Interventions

TypeNameDescription
DEVICELuxeSelf treatment at home in the peri-orbital and cheeks areas. Frequency: Daily treatment for 4 weeks followed by bi-weekly treatments for additional 4 weeks.

Timeline

Start date
2012-03-01
Primary completion
2012-12-01
Completion
2012-12-01
First posted
2012-06-13
Last updated
2014-08-11
Results posted
2014-08-11

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01618864. Inclusion in this directory is not an endorsement.

Safety and Efficacy of the Luxe Device to Treat Facial Wrinkles and Rosacea (NCT01618864) · Clinical Trials Directory